How would you like your name to appear on your certificate?

Profession

What activities did you attend at the event?

Friday, November 14 - 1:10 - 1:40 - C Freise, MD

Friday, November 14 - 1:40 - 2:00 pm - R Hirose, MD

Friday, November 14 - 2:00 - 2:20 pm - J Roberts, MD

Friday, November 14 - 2:20 - 2:50 pm - V Selby, MD

Friday, November 14 - 3:15 - 3:40 pm - D Brandman, MD and B Hameed, MD

Friday, November 14 - 3:40 - 4:05 pm - J Price, MD and S Kang, MD

Friday, November 14 - 4:05 - 4:30 pm - J Lai, MD

Friday, November 14 - 4:30 - 4:55 pm - N Terrault, MD

Friday, November 14 - 4:55 - 5:25 pm - Q&A

Saturday, November 15 - 9:00 - 10:30 am - F Yao, MD and R Kerlan, MD

Saturday, November 15 - 10:30 - 12:00 pm - D Brandman, MD and C Freise, MD

Saturday, November 15 - 9:00 - 12:00 pm - Pediatric Session

Saturday, November 15 - 12:00 - 12:30 - Q & A

Agreement

By completing this form, you attest that you have participated in all selected activities in thier entirety.

I agree

Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.

Please rate the following:

The program was relevant to my work.

Content matched stated objectives.

Usefulness of handouts/AV.

Quality of facilities.

How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?

If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situtation):

If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:

How well are you able to meet the session objectives?

Having completed the activity, please rate your ability to meet each of the following objectives:

Define the role of living donor liver transplantation in the care of the patient needing a liver transplant.

Describe the current GEOGRAPHIC disparity in organ distribution

Describe efforts to improve geographic disparity

Explain why down-staging patients outside of the Milan Criteria is successful

Discuss the failure rate of down-staging

Describe natural history of varices

Explain the impact of beta blockers on prevention of variceal bleeding

Name the types of porto-mesenteric venous thrombosis and their surgical implications for liver transplant

List the technical options for handling portal vein thrombosis and outcomes

Diagnose liver diseases unique to pregnancy

Manage pre-existing chronic liver diseases during pregnancy

Minimize risks of adverse outcomes in pregnant patients with cirrhosis

Discuss nuances of the newest HCV treatment algorithms

Discuss treatment prioritization recommendations

List HCV treatment strategies for wait-listed patients

Discuss the current system of organ allocation and diagnosis of hepatocellular carcinoma, and the management of complex cases related to liver transplant

Discuss other liver malignancies that may be treated with liver transplant

Report indications for percutaneous ablation

Dicuss the impact of obesity on liver transplant candidacy/outcomes

Identify new therapies for the treatment of HBV and HCV in children

Discuss current UNOS policy for liver allocation

Identify different options of treatment for primary prophylaxis of esophageal varices

Determine the best option for primary prophylaxis for large varices

List indications for arterial therapy for hepatocellular carcinoma

List the different types of arterial therapy for hepatocellular carcinoma

Discuss complications of liver transplant in the obese patient

Describe the complications and long term risks of donor hepatectomy

Identify strategies to reduce waitlist times for pediatric patients

Identify metabolic and cardiovascular consequences of long-term immunosuppression for pediatric liver transplant recipients

Consider methods for early recognition of these conditions and strategies for management

Objective 1: Discuss controversial and complex management issues, including portal hypertension and pulmonary HTN and patients with hepatocellular carcinoma

By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.

By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.

By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.

Objective 2: Discuss new and evolving treatments for viral hepatitis

By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.

By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.

By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.

Objective 3: Discuss liver disease and pregnancy

By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.

By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.

By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.

Please answer the following:

Do you believe this activity was appropriate for the scope of your professional activities?

Was the educational content scientifically sound?

If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?

Was the mode of education effective to learning?

If you answered "No" to any of the above questions, please explain.

Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?

If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):

Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?

If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):

How much did you learn as a result of this education program?

What specifically did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?

What problems are your patients/clients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

Basic

Intermediate

Advanced

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?

Additional comments: